# NEVIRAPINE
> **NDA202212** · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2012-04-30
## Drug
- **FDA Application Number:** NDA202212
- **Application type:** New Drug Application
- **Brand name:** NEVIRAPINE
- **Generic name:** Nevirapine
- **Active ingredients:** NEVIRAPINE
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LIMITED
- **First approval:** 2012-04-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202212)
---
*AI Analytics · CC0 1.0*